The value of health.
BACKGROUND
A major problem in cost-effectiveness studies is where to draw the line between interventions which are cost-effective and those who are not. Lacking a notion about the value of a QALY, all ultimate values to the cost-effectiveness ratio are essentially arbitrary.


METHODS
This paper presents a simple empirical model to estimate the compensating income variation of diseases and health problems. The model is estimated using data for the Netherlands.


RESULTS
The compensating income variation is between euro 20,000 and euro 90,000. This is higher than most of the ultimate values used by policy-makers to decide whether an intervention is cost-effective. Our figures are roughly similar to those found in studies about the value of a statistical life year.


CONCLUSIONS
Estimates on the compensating income variation of diseases and health problems may provide useful information on the maximum acceptable cost-effectiveness ratio of medical interventions than those currently used by policy makers.
Groot
Wim
W
van den Brink
Henriëtte Maassen
HM
D003362:Cost-Benefit Analysis / Q000379:methods*; D004194:Disease / Q000191:economics*; D036262:Empirical Research; D006240:Happiness; D005102:Health Expenditures; D006304:Health Status; D006801:Humans; D007182:Income; D017059:Models, Econometric; D009426:Netherlands; D010549:Personal Satisfaction; D019057:Quality-Adjusted Life Years